CASC
Geode Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-389,041
| Closed | -$1.44M | – | 4113 |
|
|
2017
Q4 | $1.44M | Buy |
389,041
+42,439
| +12% | +$157K | ﹤0.01% | 2944 |
|
|
2017
Q3 | $1.42M | Buy |
346,602
+40,423
| +13% | +$165K | ﹤0.01% | 2951 |
|
|
2017
Q2 | $1.14M | Buy |
306,179
+53,245
| +21% | +$198K | ﹤0.01% | 3050 |
|
|
2017
Q1 | $1.05M | Buy |
252,934
+137,350
| +119% | +$569K | ﹤0.01% | 2993 |
|
|
2016
Q4 | $498K | Sell |
115,584
-563,811
| -83% | -$2.43M | ﹤0.01% | 3265 |
|
|
2016
Q3 | $1.11M | Buy |
679,395
+146,881
| +28% | +$241K | ﹤0.01% | 2883 |
|
|
2016
Q2 | $502K | Sell |
532,514
-97,316
| -15% | -$91.7K | ﹤0.01% | 3223 |
|
|
2016
Q1 | $799 | Buy |
629,830
+6,810
| +1% | +$9 | ﹤0.01% | 3002 |
|
|
2015
Q4 | $1.38M | Buy |
623,020
+14,379
| +2% | +$31.9K | ﹤0.01% | 2720 |
|
|
2015
Q3 | $1.67M | Buy |
608,641
+5,807
| +1% | +$15.9K | ﹤0.01% | 2561 |
|
|
2015
Q2 | $2.25M | Buy |
602,834
+26,757
| +5% | +$100K | ﹤0.01% | 2420 |
|
|
2015
Q1 | $939K | Buy |
576,077
+116,008
| +25% | +$189K | ﹤0.01% | 2911 |
|
|
2014
Q4 | $874K | Buy |
460,069
+51,354
| +13% | +$97.6K | ﹤0.01% | 2927 |
|
|
2014
Q3 | $784K | Buy |
408,715
+74,858
| +22% | +$144K | ﹤0.01% | 2938 |
|
|
2014
Q2 | $1.08M | Buy |
333,857
+82,671
| +33% | +$268K | ﹤0.01% | 2758 |
|
|
2014
Q1 | $751K | Buy |
251,186
+39,983
| +19% | +$120K | ﹤0.01% | 2946 |
|
|
2013
Q4 | $371K | Buy |
211,203
+320
| +0.2% | +$562 | ﹤0.01% | 3205 |
|
|
2013
Q3 | $434K | Buy |
210,883
+70
| +0% | +$144 | ﹤0.01% | 3017 |
|
|
2013
Q2 | $329K | Buy |
+210,813
| New | +$329K | ﹤0.01% | 3056 |
|